<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-2-2.anc" start="7130" end="7134" sStart="7110" offset="20" sid="r11.true.j.0595" wn="1" wnkey="true%3:00:00::" text="This observation is true for both class I and class II MHC-peptide complexes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-2-2.anc" start="11688" end="11695" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="&lt;b&gt;Success&lt;/b&gt; in peptides designed to bind in the MHC groove has been achieved by carefully dissecting side chain interactions and placing appropriate flexible residues at key positions in the peptide." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-2-2.anc" start="11688" end="11695" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="&lt;b&gt;Success&lt;/b&gt; in peptides designed to bind in the MHC groove has been achieved by carefully dissecting side chain interactions and placing appropriate flexible residues at key positions in the peptide." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-2-2.anc" start="305" end="315" sStart="null" offset="74" sid="r10.particular.j.0846" wn="2" wnkey="particular%5:00:02:specific:00" text="[ 1 2 ] From a classical approach of mapping an MHC allele with a particular disease, the focus has shifted to determine the specific peptides presented to MHC molecules with clearly defined sequences." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1472-6807-2-2.anc" start="11101" end="11106" sStart="null" offset="0" sid="null" wn="3" wnkey="know%2:31:02::" text="[ 25 ] Despite sufficient knowledge on the chemical nature of molecular interactions very little is &lt;b&gt;known&lt;/b&gt; about the common interaction types for MHC-peptide complexes." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-2-2.anc" start="12728" end="12736" sStart="null" offset="209" sid="r11.function.n.0836" wn="2" wnkey="function%1:07:00::" text="The current challenge in MHC-peptide binding prediction is twofold: (1) accurate prediction of peptide backbone conformation for subsequent sidechain packing (2) accurate estimation of function by such predictions for quantitative MHC-peptide binding studies." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-2-2.anc" start="15503" end="15512" sStart="null" offset="65" sid="r8.1.different.j.0432" wn="4" wnkey="different%5:00:01:other:00" text="The two sets of crystal complexes are examined for the different types of inter-atomic interactions at the interface." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-2-2.anc" start="11117" end="11123" sStart="null" offset="132" sid="r10.common.j.0895" wn="4" wnkey="common%5:00:00:familiar:02" text="[ 25 ] Despite sufficient knowledge on the chemical nature of molecular interactions very little is known about the common interaction types for MHC-peptide complexes." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-2-2.anc" start="12248" end="12254" sStart="null" offset="126" sid="r10.common.j.0659" wn="2" wnkey="common%3:00:01::" text="The backbone conformation adopted by the peptide in the groove is important for maintaining the predominantly common SB interactions." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-2-2.anc" start="5227" end="5233" sStart="null" offset="75" sid="r10.common.j.0308" wn="3" wnkey="common%5:00:00:shared:00" text="However, there is no comprehensive report available describing the common types of interactions in a set of MHC-peptide complexes characterized by MHC allele variation and peptide sequence diversity." />
  </sentences>
</list>